Deep-pocketed investors have adopted a bearish approach towards Pfizer (NYSE:PFE), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PFE usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Pfizer. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 44% leaning bullish and 55% bearish. Among these notable options, 6 are puts, totaling $448,868, and 3 are calls, amounting to $1,526,446.
Expected Price Movements
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $18.0 to $28.0 for Pfizer over the last 3 months.
Volume & Open Interest Development
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Pfizer's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Pfizer's significant trades, within a strike price range of $18.0 to $28.0, over the past month.
Pfizer Option Activity Analysis: Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PFE | CALL | TRADE | BULLISH | 01/15/27 | $2.2 | $2.05 | $2.15 | $27.00 | $1.4M | 54.2K | 6.6K |
| PFE | PUT | SWEEP | BEARISH | 03/20/26 | $0.75 | $0.72 | $0.75 | $27.00 | $148.2K | 14.1K | 398 |
| PFE | PUT | SWEEP | BULLISH | 05/15/26 | $2.47 | $2.22 | $2.35 | $28.00 | $92.1K | 149 | 392 |
| PFE | PUT | SWEEP | BULLISH | 06/17/27 | $3.7 | $3.4 | $3.53 | $27.00 | $83.4K | 497 | 236 |
| PFE | CALL | TRADE | BULLISH | 01/15/27 | $2.12 | $2.05 | $2.12 | $27.00 | $70.5K | 54.2K | 7.0K |
About Pfizer
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
After a thorough review of the options trading surrounding Pfizer, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Current Position of Pfizer
- Currently trading with a volume of 21,247,706, the PFE's price is down by -0.28%, now at $26.38.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 54 days.
Expert Opinions on Pfizer
4 market experts have recently issued ratings for this stock, with a consensus target price of $28.0.
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Neutral with a new price target of $27.
- Reflecting concerns, an analyst from Barclays lowers its rating to Underweight with a new price target of $25.
- An analyst from Argus Research upgraded its action to Buy with a price target of $35.
- Reflecting concerns, an analyst from RBC Capital lowers its rating to Underperform with a new price target of $25.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements.
Login to comment